Cimpress (3UF) AI Stock Analysis

Cimpress

(Frankfurt:3UF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Mass-Customization ModelCimpress’s mass-customization model combines software, standardized workflows, and scaled production to serve many small orders efficiently. This operating architecture can support repeat purchasing, improve utilization, and create durable cost advantages as product breadth and customer volume expand.

Negative Factors

High Leverage and Negative EquityHigh debt combined with persistent negative equity leaves Cimpress with a limited balance-sheet cushion if demand or profitability weakens. Leverage can also constrain capital allocation and increase the importance of sustained cash generation, even though management expects future deleveraging.

Cimpress (3UF) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.40B
Dividend Yield: ―
Average Volume (3M): 50
Price to Earnings (P/E): 16.3
Beta (1Y): 0.07
Revenue Growth: 4.50%
EPS Growth: 124.28%
Country: Germany
Employees: 16,000
Sector: Industrials
Sector Strength: 63
Industry: Specialty Business Services

Cimpress Business Overview & Revenue Model

Company Description

Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. It operates through five segments: Vista, PrintBrothers, The Print Group, National Pen, and All Other Businesses. The com...

Cimpress Earnings Call Summary

Earnings Call Date:Oct 27, 2026(Q1-2027)|% Change Since:-13.30%|Next Earnings Date:Feb 02, 2027

Earnings Call SentimentNeutral

The call presented a mixed outlook. The first quarter missed expectations, with organic growth below target, adjusted EBITDA down 9%, continued pressure from legacy products and channels, and cost headwinds from manufacturing startups, tariffs, energy, and restructuring. However, management maintained fiscal 2027 and fiscal 2028 guidance, cited strong high-value customer growth, improving cash flow, acquisition progress, AI and manufacturing initiatives, and a clear cost-reduction plan. The positive strategic and forward-looking commentary broadly balanced the weaker quarterly performance.

Positive Updates

Fiscal 2027 Guidance Maintained

Management maintained fiscal 2027 guidance for reported revenue growth of at least 7%, organic constant currency growth of at least 3%, adjusted EBITDA of at least $520 million, and adjusted free cash flow of approximately $200 million. Management also maintained fiscal 2028 targets of 4%-6% organic constant currency growth, at least $615 million of adjusted EBITDA, and approximately 45% conversion of EBITDA to adjusted free cash flow.

Negative Updates

Q1 Results Below Expectations

Robert Keane stated that first-quarter fiscal 2027 financial results were below expectations. Management said the quarter included specific headwinds, although it did not change its conviction in the full-year guidance or long-term trajectory.

Company Guidance

Cimpress is maintaining its fiscal 2027 guidance for reported revenue growth of at least 7%, organic constant currency growth of at least 3%, adjusted EBITDA of at least $520 million, and adjusted free cash flow of approximately $200 million; for fiscal 2028, it continues to target 4%-6% organic constant currency growth, at least $615 million of adjusted EBITDA, and approximately 45% conversion of that EBITDA to adjusted free cash flow. The fiscal 2027 bridge includes tuck-in M&A contributing $18 million-$21 million, currency contribution of $5 million-$10 million, and about $25 million of in-year cost savings; increased revenue from acquisitions is expected to be $165 million-$175 million, with an in-year increase of EBITDA of $18 million-$21 million. The company continues to expect net leverage to be approximately 2.5 times as it finishes this year and meaningfully below 2.0 times at the end of fiscal 2028, subject to capital allocation choices that we may make, while manufacturing startup costs and new Canadian tariffs are expected to reduce in the second half of this year, and profit and cash flow growth are expected to build from Q2 through the rest of fiscal 2027 and into fiscal 2028.

Cimpress Risk Analysis

Cimpress disclosed 35 risk factors in its most recent earnings report. Cimpress reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Cimpress Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:3UF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CTAS	83Outperform	$87.29B	42.85	42.08%	0.85%	9.51%	12.19%
EBF	78Outperform	$541.29M	13.88	12.58%	4.74%	2.27%	-5.62%
DLX	66Neutral	$1.04B	9.99	14.63%	5.31%	0.30%	71.14%
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
HHS	51Neutral	$28.85M	-5.06	-30.13%	―	-11.62%	-87.59%
QUAD	48Neutral	$370.80M	13.16	21.18%	5.21%	-4.88%	28.67%

* Industrials Sector Average

Performance Comparison

DE:3UF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:3UF	Cimpress NV	63.25	2.75	4.55%
CTAS	Cintas	219.82	39.59	21.97%
DLX	Deluxe Corp.	22.59	5.40	31.40%
EBF	Ennis Inc	21.38	5.20	32.12%
HHS	Harte-Hanks, Inc.	3.87	0.86	28.57%
QUAD	Quad/Graphics, Inc. Class A	7.20	2.05	39.75%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Cimpress AI Stock Analysis